Premium
TransEnterix Inc New (TRXC)
AMEX
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Effective on March 5, 2021, Asensus Surgical will trade under ticker symbol ASXC Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: ASXC), a medical device company that is...
Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of...
Indications Expand to Include New Procedures in Large General Surgery Market Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is...
Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of...
New name reflects commitment to pioneering a new era of Performance-Guided Surgery to help improve surgical results and patient outcomes TransEnterix, Inc. (NYSE American:TRXC), a medical device...
Agreement with the Amsterdam Skills Centre Establishes Second European Surgical Training Site for Senhance Digital Laparoscopy TransEnterix, Inc. (NYSE American:TRXC), a medical device company...
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced...
Proceeds from offering, in combination with recent financing activity, extends cash runway into 2024 TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the...
TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...
TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| AAPYKurv Yield Premium Strategy Apple AAPL ETF | US$ 0,00 (0,00%) | 0 |
| AAPXT Rex 2X Long Apple Daily Target ETF | US$ 0,00 (0,00%) | 0 |
| AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | US$ 0,00 (0,00%) | 0 |
| AAAUGoldman Sachs Physical Gold ETF Shares | US$ 0,00 (0,00%) | 0 |
| AAAAlternative Access First Priority CLO Bond ETF | US$ 0,00 (0,00%) | 0 |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
